Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

BACKGROUND: This study aimed to verify the safety and efficacy, including glycemic control, of the selective dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes. METHODS: This study used a multi-center, open-label, prospective observational design. Type 2 diabetes patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Takamiya, Yosuke, Kobayashi, Kunihisa, Kudo, Tadachika, Okuda, Tetsu, Okamura, Keisuke, Shirai, Kazuyuki, Urata, Hidenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331869/
https://www.ncbi.nlm.nih.gov/pubmed/32655736
http://dx.doi.org/10.14740/jocmr4224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331869/
https://www.ncbi.nlm.nih.gov/pubmed/32655736
http://dx.doi.org/10.14740/jocmr4224

Ejemplares similares